BRPI0815500A2 - compostos terapêuticos, bem como seus usos - Google Patents
compostos terapêuticos, bem como seus usosInfo
- Publication number
- BRPI0815500A2 BRPI0815500A2 BRPI0815500A BRPI0815500A BRPI0815500A2 BR PI0815500 A2 BRPI0815500 A2 BR PI0815500A2 BR PI0815500 A BRPI0815500 A BR PI0815500A BR PI0815500 A BRPI0815500 A BR PI0815500A BR PI0815500 A2 BRPI0815500 A2 BR PI0815500A2
- Authority
- BR
- Brazil
- Prior art keywords
- well
- therapeutic compounds
- therapeutic
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/44—Nitrogen atoms not forming part of a nitro radical
- C07D233/50—Nitrogen atoms not forming part of a nitro radical with carbocyclic radicals directly attached to said nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D263/28—Nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/08—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D277/12—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/18—Nitrogen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Ophthalmology & Optometry (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US95596407P | 2007-08-15 | 2007-08-15 | |
PCT/US2008/073108 WO2009023757A1 (en) | 2007-08-15 | 2008-08-14 | Therapeutic compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0815500A2 true BRPI0815500A2 (pt) | 2017-05-30 |
Family
ID=39930736
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0815500A BRPI0815500A2 (pt) | 2007-08-15 | 2008-08-14 | compostos terapêuticos, bem como seus usos |
Country Status (10)
Country | Link |
---|---|
US (1) | US20110178143A1 (pt) |
EP (1) | EP2188261A1 (pt) |
JP (2) | JP2010536780A (pt) |
KR (1) | KR20100046256A (pt) |
CN (1) | CN101855213B (pt) |
AU (1) | AU2008286823A1 (pt) |
BR (1) | BRPI0815500A2 (pt) |
CA (1) | CA2696404A1 (pt) |
RU (1) | RU2491278C2 (pt) |
WO (1) | WO2009023757A1 (pt) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009023758A1 (en) * | 2007-08-15 | 2009-02-19 | Allergan, Inc. | Heterocyclyl substituted fused carbocyles useful in the treatment of conditions such as glaucoma and pain |
US20120309796A1 (en) | 2011-06-06 | 2012-12-06 | Fariborz Firooznia | Benzocycloheptene acetic acids |
WO2013186089A2 (en) | 2012-06-14 | 2013-12-19 | Basf Se | Pesticidal methods using substituted 3-pyridyl thiazole compounds and derivatives for combating animal pests |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2870161A (en) * | 1957-07-08 | 1959-01-20 | Pfizer & Co C | 2-(1-indanyl amino)-oxazolines |
US2883410A (en) * | 1957-07-08 | 1959-04-21 | Pfizer & Co C | N-(1-indanyl)-n'-(beta-substituted ethyl)-ureas |
US2870159A (en) * | 1957-07-08 | 1959-01-20 | Pfizer & Co C | Hydrogenated 2-(1-naphthylamino)-oxazolines |
US3636219A (en) * | 1964-03-02 | 1972-01-18 | Du Pont | Anticholinergic compositions containing certain thiazolines or imidazolines |
AT330769B (de) * | 1974-04-05 | 1976-07-26 | Chemie Linz Ag | Verfahren zur herstellung von 2-arylamino- 2-imidazolin-derivaten und ihren salzen |
US4256755A (en) * | 1980-04-28 | 1981-03-17 | E. I. Du Pont De Nemours & Company | Method of using N-substituted dihydro-2-oxazolamines as analgesics |
GB8610909D0 (en) * | 1986-05-03 | 1986-06-11 | Beecham Group Plc | Compounds |
DE19514579A1 (de) * | 1995-04-20 | 1996-10-24 | Boehringer Ingelheim Kg | Verwendung von alpha¶1¶¶L¶-Agonisten zur Behandlung der Harninkontinenz |
AU715350B2 (en) * | 1995-05-12 | 2000-01-20 | Allergan, Inc. | Aryl-imidazolines and aryl-imidazoles useful as alpha-2 adrenergic agonists without cardiovascular side effects |
US7141597B2 (en) * | 2003-09-12 | 2006-11-28 | Allergan, Inc. | Nonsedating α-2 agonists |
JPWO2005055999A1 (ja) * | 2003-12-08 | 2007-07-05 | 日本新薬株式会社 | 抗コリン作用剤 |
GB0516706D0 (en) * | 2005-08-15 | 2005-09-21 | Syngenta Participations Ag | Chemical compounds |
PE20070705A1 (es) * | 2005-11-25 | 2007-08-23 | Basf Ag | Compuestos de indanil - y tetrahidronaftil-amino-azolina para combatir pestes animales |
WO2007093292A2 (en) * | 2006-02-15 | 2007-08-23 | Bayer Cropscience Ag | Insecticidal substituted amino heterocyclic and heteroaryl derivatives |
WO2008115141A1 (en) * | 2007-03-19 | 2008-09-25 | Albireo Ab | 4, 5-dihydro-1,3-thiazol-2-amine derivatives and their use in the treatment of respiratory, cardiovascular, neurological or gastrointestinal disorders |
WO2009023758A1 (en) * | 2007-08-15 | 2009-02-19 | Allergan, Inc. | Heterocyclyl substituted fused carbocyles useful in the treatment of conditions such as glaucoma and pain |
-
2008
- 2008-08-14 AU AU2008286823A patent/AU2008286823A1/en not_active Abandoned
- 2008-08-14 US US12/673,301 patent/US20110178143A1/en not_active Abandoned
- 2008-08-14 BR BRPI0815500A patent/BRPI0815500A2/pt not_active IP Right Cessation
- 2008-08-14 WO PCT/US2008/073108 patent/WO2009023757A1/en active Application Filing
- 2008-08-14 EP EP08797858A patent/EP2188261A1/en not_active Withdrawn
- 2008-08-14 RU RU2010108387/04A patent/RU2491278C2/ru not_active IP Right Cessation
- 2008-08-14 CN CN200880109728.0A patent/CN101855213B/zh not_active Expired - Fee Related
- 2008-08-14 JP JP2010521168A patent/JP2010536780A/ja active Pending
- 2008-08-14 CA CA2696404A patent/CA2696404A1/en not_active Abandoned
- 2008-08-14 KR KR1020107005726A patent/KR20100046256A/ko not_active Application Discontinuation
-
2014
- 2014-01-31 JP JP2014016607A patent/JP2014139175A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
JP2010536780A (ja) | 2010-12-02 |
JP2014139175A (ja) | 2014-07-31 |
CN101855213B (zh) | 2014-09-10 |
AU2008286823A1 (en) | 2009-02-19 |
CA2696404A1 (en) | 2009-02-19 |
RU2010108387A (ru) | 2011-09-20 |
KR20100046256A (ko) | 2010-05-06 |
EP2188261A1 (en) | 2010-05-26 |
RU2491278C2 (ru) | 2013-08-27 |
CN101855213A (zh) | 2010-10-06 |
US20110178143A1 (en) | 2011-07-21 |
WO2009023757A1 (en) | 2009-02-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI1016150A2 (pt) | compostos heterocíclicos e seus usos. | |
BRPI0817881A2 (pt) | Compostos orgânicos e seus usos | |
BRPI0923533A2 (pt) | espaçador sinusal frontal | |
BRPI0922845A2 (pt) | pirazol-4-n-alcoxicarboxamidas como microbiocidas | |
BRPI0908502A2 (pt) | aines oftálmicos como adjuvantes | |
BRPI0919295A2 (pt) | 1h-benzimidazol-5-carboxamidas como agentes anti-inflamatórios. | |
BRPI0816075A2 (pt) | 2-(fenil substituído)-6-amino-5-alcóxi, tioalcóxi e aminoalquil-4-pirimidinacarboxilatos e seus usos como herbicidas | |
DK2324831T3 (da) | Pirfenidonterapi, som undgår fluvoxamin | |
BRPI1008899A2 (pt) | derivados 3,3´-espiroindolinona como agentes anticâncer | |
BRPI0911594A2 (pt) | di-hidropirazolonas substistuídas, seu processo de preparação e seu uso, bem como medicamentos | |
BRPI0910534A2 (pt) | terapia antiviral | |
DE502008001632D1 (de) | Karosserieaufbau | |
DK2173831T3 (da) | Brøndbehandling | |
BRPI0820410A2 (pt) | Lactans substituídos terapêuticos | |
BRPI0911179A2 (pt) | 2-alquinil-6-piridin-2-ilpiridazinonas, 2-alquinil-6-piridin-2-il-di-hidropiridazinonas, 2-alquinil-6-pirimidin-2-ilpiridazinonas e 2-alquinil-6-pirimidin-2-il-di-hidropiridazinonas e seus usos como fungicidas | |
BRPI0920502A2 (pt) | compostos cicloundecadepsipeptídeos e seu uso como medicamento | |
BRPI0818598A2 (pt) | agentes terapêuticos - 802 | |
BRPI0807804A2 (pt) | " arilciclopentenos substituídos como agentes terapêuticos ". | |
BRPI0817618A2 (pt) | Lactose macrocíclicas como fragrâncias | |
BRPI0910931A2 (pt) | ciclopentanos substituídos terapêuticos | |
BRPI0910991A2 (pt) | piperidinas substituídas como compostos terapêuticos | |
BRPI0918062A2 (pt) | Tienilaminopirimidinas como fungicidas | |
BRPI0815500A2 (pt) | compostos terapêuticos, bem como seus usos | |
BRPI0909764A2 (pt) | compostos terapêuticos | |
CU23885B1 (es) | Estratrienos 8-beta sustituidos como estrógenos de acción selectiva |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] | ||
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |